754 related articles for article (PubMed ID: 18771428)
1. Assessment and management of hypertension in patients with type 2 diabetes.
Thomas MC; Atkins R
Intern Med J; 2009 Mar; 39(3):143-9. PubMed ID: 18771428
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
[TBL] [Abstract][Full Text] [Related]
3. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
4. [Inadequate treatment and control of arterial hypertension in patients with type 2 diabetes mellitus].
Boero R; Prodi E; Borsa S; Berti V; Fiorio E; Ferraro L; Massara C; Quarello F
G Ital Nefrol; 2002; 19(4):413-8. PubMed ID: 12369043
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice.
Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O
J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492
[TBL] [Abstract][Full Text] [Related]
6. How early should blood pressure control be achieved for optimal cardiovascular outcomes?
Weir MR; Zappe D; Orloski LA; Sowers JR
J Hum Hypertens; 2011 Apr; 25(4):211-7. PubMed ID: 20596060
[TBL] [Abstract][Full Text] [Related]
7. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function.
Marchesi C; Maresca AM; Solbiati F; Franzetti I; Laurita E; Nicolini E; Gianni M; Guasti L; Marnini P; Venco A; Grandi AM
Am J Hypertens; 2007 Oct; 20(10):1079-84. PubMed ID: 17903691
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN).
McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT;
Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501
[TBL] [Abstract][Full Text] [Related]
9. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
10. [Hypertension management in general practice in Iceland].
Jensdóttir JO; Sigurethsson EL; Thornorgeirsson G
Laeknabladid; 2006 May; 92(5):375-80. PubMed ID: 16741320
[TBL] [Abstract][Full Text] [Related]
11. Successful cardiovascular risk reduction in Type 2 diabetes by nurse-led care using an open clinical algorithm.
Woodward A; Wallymahmed M; Wilding J; Gill G
Diabet Med; 2006 Jul; 23(7):780-7. PubMed ID: 16842484
[TBL] [Abstract][Full Text] [Related]
12. Inertia or inaction? Blood pressure management and cardiovascular risk in diabetes.
Owen AJ; Retegan C; Rockell M; Jennings G; Reid CM
Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):643-7. PubMed ID: 19076166
[TBL] [Abstract][Full Text] [Related]
13. Hypertension in diabetes: trends in clinical control in repeated large-scale national surveys from Sweden.
Nilsson PM; Gudbjörnsdottir S; Eliasson B; Cederholm J;
J Hum Hypertens; 2003 Jan; 17(1):37-44. PubMed ID: 12571615
[TBL] [Abstract][Full Text] [Related]
14. Treating hypertension by rational use of diuretics: results of the Russian ARGUS-2 Study.
Kobalava ZD; Kotovskaya YV; Villevalde SV; Moiseev VS;
Curr Med Res Opin; 2009 Sep; 25(9):2229-37. PubMed ID: 19622008
[TBL] [Abstract][Full Text] [Related]
15. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
[TBL] [Abstract][Full Text] [Related]
17. A cluster randomised controlled trial of the effect of a treatment algorithm for hypertension in patients with type 2 diabetes.
Bebb C; Kendrick D; Coupland C; Madeley R; Stewart J; Brown K; Burden R; Sturrock N
Br J Gen Pract; 2007 Feb; 57(535):136-43. PubMed ID: 17263930
[TBL] [Abstract][Full Text] [Related]
18. The need for improved medical management of patients with concomitant hypertension and type 2 diabetes mellitus.
Godley PJ; Maue SK; Farrelly EW; Frech F
Am J Manag Care; 2005 Apr; 11(4):206-10. PubMed ID: 15839181
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the achieved blood pressure and the incidence of cardiovascular events in Japanese hypertensive patients with complications: a sub-analysis of the CASE-J trial.
Ogihara T; Saruta T; Rakugi H; Fujimoto A; Ueshima K; Yasuno S; Oba K; Takeda K; Higaki J; Nakao K;
Hypertens Res; 2009 Apr; 32(4):248-54. PubMed ID: 19347033
[TBL] [Abstract][Full Text] [Related]
20. Trends in the management of arterial hypertension in patients with type 1 and insulin-treated type 2 diabetes mellitus over a period of 10 years (1989/1990-1994/1995). Results of the JEVIN trial.
Schiel R; Müller UA; Beltschikow W; Stein G
J Diabetes Complications; 2006; 20(5):273-9. PubMed ID: 16949513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
